Yishan Zhou | Cardiology | Most Reader’s Article Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Yishan Zhou | Cardiology | Most Reader's Article Award

The Seventh Clinical College of Guangzhou University of Chinese Medicine | China

Ms. Zhou Yishan is a dedicated researcher in Chinese Internal Medicine whose academic and professional journey reflects consistent excellence and a strong commitment to advancing integrative medical practice. She earned her Bachelor of Medicine in Clinical Medicine (Integrated Chinese and Western Medicine) from Guangzhou Medical University, followed by a Master of Medicine in Chinese Internal Medicine (Nephrology) from Guangzhou University of Chinese Medicine. During her postgraduate studies, she served as a core project member in the Sanming Project of Medicine in Shenzhen, contributing to research initiatives focused on clinical nephrology. She also played a key role in the Baoan District Association of Chinese Medicine Promotion Project, working on the clinical evaluation of the Yiqi Huoxue Fumigation-Wash formula for preventing early failure of autogenous arteriovenous fistulas, demonstrating her commitment to improving patient outcomes through evidence-based traditional therapies. Earlier in her academic career, she served as a Research Assistant at the National Center for Respiratory Medicine, supporting Professor Sun’s team through data collection, literature reviews, and preparation of research materials, which strengthened her multidisciplinary foundation. Her achievements have been recognized through honors such as Outstanding Graduate and University Merit Student, along with multiple First-Class and Second-Class Scholarships. With 2 published documents, 11 citations, and an h-index of 1, Ms. Zhou continues to build a promising research profile grounded in rigorous clinical investigation and integrative medical innovation.

Profile: Scopus

Featured Publications

Zhou, Y., Zou, Y., Cao, Y., et al. (2025). The association between the cardiometabolic index and hyperuricemia: 2011–2016 NHANES. Frontiers in Endocrinology, 16, 1545968.

Cao, Y., Zhou, Y., Zhong, Y., Liao, X., Chen, X., & Pi, Y. (2024). Association between oxidative balance score in adults with and without chronic kidney disease: 2011–2028 NHANES. Frontiers in Nutrition, 11, 1374719.

Zhou, Y., et al. (2025). Clinical observation on Yiqi Huoxue Fumigation-Wash Formula for preventing early failure of autogenous arteriovenous fistula. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 31(08), 114–120, 127.

Zhou, Y., et al. (2024). Exploration on the clinical application of Ephedrae Herba in stimulating Yang Qi. Journal of Guangzhou University of Traditional Chinese Medicine, 41(01), 234–239.

Yifan Zhou | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Yifan Zhou | Cardiovascular Disease | Best Researcher Award

Hunan Normal University | China

Dr. Yifan Zhou is a dedicated researcher in the field of orthopedics, with a strong focus on musculoskeletal health, metabolic regulation, and their interrelated effects on chronic diseases. Affiliated with prominent medical institutions in China, he has made meaningful contributions to understanding how metabolic and physiological factors influence skeletal muscle mass, body composition, and overall health outcomes. He has published 3 scientific documents, achieving an h-index of 1 and a total of 4 citations from 4 referencing sources, reflecting the growing recognition of his work within the scientific community. His studies have explored key associations such as the relationship between the metabolic score for visceral fat index and skeletal muscle mass, the role of the cardiometabolic index in obstructive sleep apnea, and the link between liver function indicators and sarcopenia among middle-aged adults. Additionally, his work examines the connection between the triglyceride-glucose index and depression, highlighting the mediating effects of hypertension and smoking in obese individuals. His research has been published in respected journals including Lipids in Health and Disease, Frontiers in Endocrinology, Frontiers in Nutrition, and the Journal of Affective Disorders. Beyond his research, he also contributes as a reviewer for major international journals such as Scientific Reports, European Spine Journal, BMC Public Health, and European Journal of Medical Research.

Profiles: Scopus | Orcid

Featured Publications

Zhou, Y., Su, X., Tan, H., & Xiao, J. (2024). Association between metabolic score for visceral fat index and BMI-adjusted skeletal muscle mass index in American adults. Lipids in Health and Disease.

Zhou, Y., Yu, J., Tan, H., & Xiao, J. (2024). Association between cardiometabolic index and obstructive sleep apnea and the mediating role of smoking: A cross-sectional study. Frontiers in Endocrinology (Lausanne).

Zhou, Y., Yu, J., Wu, A., Tan, H., & Xiao, J. (2024). Association between albumin–bilirubin score and sarcopenia in middle-aged Americans: A cross-sectional study. Frontiers in Nutrition.

Zhou, Y., Yu, J., Qi, L., Tan, H., & Xiao, J. (2024). Association between triglyceride–glucose index and depression and the mediating role of hypertension: A cross-sectional study of obese adults. Journal of Affective Disorders.

Thilini Jayasinghe | Cardiovascular Researches | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Thilini Jayasinghe | Cardiovascular Researches | Best Research Article Award

The Univeristy of Sydney | Australia

Dr. Thilini Jayasinghe is a dedicated and forward-thinking early-career researcher specializing in the complex interplay between the oral and gut microbiomes, inflammation, and nutrition in chronic disease contexts. She has authored 25 documents, comprising peer-reviewed publications, book chapters, and research articles, which have collectively accumulated 474 citations, reflecting the significance and reach of her work within the scientific community. Her research achievements are further highlighted by an h-index of 11, demonstrating both productivity and impact. Over the past eight years, Dr. Jayasinghe has contributed to and led multidisciplinary studies spanning epidemiological, clinical, and pre-clinical models, collaborating with teams across eight countries, with more than half of her publications arising from international partnerships. She has successfully secured competitive research grants and played a pivotal role in ethics submissions, clinical trial protocols, and biobank initiatives. Her technical expertise encompasses molecular microbiology, bioinformatics, multi-omics integration, animal model research, and clinical trial design, alongside strong project leadership and mentorship skills. Currently serving as a Research Fellow at the University of Sydney, she leads translational research projects, supervises students at various academic levels, and contributes to teaching programs. Dr. Jayasinghe’s work continues to advance understanding of diet–microbiome–inflammation interactions, aiming to improve human health outcomes globally.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Wilson, B. C., Zuppi, M., Derraik, J. G. B., Albert, B. B., Tweedie-Cullen, R. Y., Leong, K. S. W., Beck, K. L., Vatanen, T., O’Sullivan, J. M., Cutfield, W. S., & on behalf of the Gut Bugs Study Group (including Jayasinghe, T.). (2025). Long-term health outcomes in adolescents with obesity treated with faecal microbiota transplantation: 4-year follow-up. Nature Communications, 16, 7786.

Jayasinghe, T., Jenkins, J., Medara, N., Choowong, P., Dharmarathne, G., Kong, F., Cho, H., Kim, S. H., Zhang, Y. G., Franco-Duarte, R., Eberhard, J., & Spahr, A. (2025). Dietary fibre modulates body composition, blood glucose, inflammation, microbiome, and metabolome in a murine model of periodontitis. Nutrients, 17(7), 1146.

Dharmarathne, G., Kazi, S., King, S., & Jayasinghe, T. N. (2024). The bidirectional relationship between cardiovascular medications and oral and gut microbiome health: A comprehensive review. Microorganisms, 12, 2246.

Jayasinghe, T. N., & Spahr, A. (2023). Dietary supplementation of omega-3 fatty acids could be used as an adjunct therapy to nonsurgical periodontal treatment. Journal of Evidence-Based Dental Practice, 101925.

Chopra, A., Jayasinghe, T. N., & Eberhard, J. (2022). Are inflamed periodontal tissues endogenous source of advanced glycation end-products (AGEs) in individuals with and without diabetes mellitus? A systematic review. Biomolecules, 12, 642.

 

Heng Zhang | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Heng Zhang | Cardiology | Best Researcher Award

Fuwai Hospital, National Center for Cardiovascular Diseases | China

Author Profile

Scopus

Orcid ID

HENG ZHANG, M.D., PH.D. 🩺🫀

Dr. Heng Zhang is a distinguished medical professional specializing in cardiovascular surgery, with substantial contributions to the field of cardiovascular disease research, clinical practice, and health innovation. Holding a dual degree in medicine (M.D.) and a doctorate in philosophy (Ph.D.), Dr. Zhang’s academic and professional endeavors continue to shape the landscape of modern cardiovascular surgery, offering valuable insights into risk prediction, coronary revascularization, and the optimization of treatment strategies for cardiovascular diseases. His current role as an Associate Chief Physician at Fuwai Hospital, National Clinical Research Center of Cardiovascular Diseases, further cements his impact on the advancement of medical science.

EARLY ACADEMIC PURSUITS 🎓

Dr. Heng Zhang's academic journey began with an M.D. degree from Tianjin Medical University, where he graduated in 2010. During his studies, Dr. Zhang displayed a keen interest in cardiovascular health, which led him to pursue a Ph.D. in Cardiovascular Disease from Peking Union Medical College in 2015. Throughout his academic path, he also participated in key research exchanges, including a Visiting Scholar program in the USA at Duke Clinical Research Institute, further broadening his expertise in cardiovascular outcomes research and clinical performance measures.

PROFESSIONAL ENDEAVORS 👨‍⚕️🏥

Dr. Zhang’s clinical training began in 2009 with an internship at Nankai Hospital and continued through various stages of residency, including Peking Union Medical College Hospital and Fuwai Hospital. By 2015, he began specializing in cardiovascular surgery, eventually becoming an Attending Physician at Fuwai Hospital in 2019. His extensive clinical exposure includes pediatric and adult cardiac surgery, where he gained invaluable experience in treating complex heart conditions and improving patient outcomes through innovative surgical techniques.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY🔬💡

Dr. Zhang’s research has primarily focused on cardiovascular surgery registry, coronary revascularization risk prediction, and optimizing diagnostic and treatment strategies for cardiovascular conditions. He is deeply engaged in cardiovascular outcomes research, with particular attention to improving clinical performance measures and treatment protocols for heart diseases.

As the principal investigator and host of multiple high-impact research projects, Dr. Zhang has led groundbreaking studies such as evaluating the efficacy and safety of RN medications in preventing myocardial injury caused by ischemia-reperfusion and examining macrophage subtypes in coronary atherosclerosis. He has also significantly contributed to understanding valve replacement surgery and the long-term effects of heart valve interventions.

IMPACT AND INFLUENCE 🌍💪

Dr. Zhang's contributions to cardiovascular medicine have left a profound mark on clinical practice and research. Through his involvement in various research grants, including National Key Research and Development Plans of China and the Natural Science Foundation of China, Dr. Zhang has been pivotal in advancing both the theoretical and practical aspects of cardiovascular disease treatment and prevention. His work has also led to a shift in how cardiovascular surgeries are approached, particularly regarding patient-specific interventions in coronary artery malformation and atrial fibrillation.

His research projects have earned him several prestigious accolades, such as the Outstanding Reviewer for the Chinese Clinical Journal of Thoracic and Cardiovascular Surgery and the American Heart Association Travel Stipend Award. Dr. Zhang’s clinical and academic contributions are shaping future medical protocols, paving the way for a more personalized approach to heart disease treatment.

ACADEMIC CITES & HONORS 🏅📚

Dr. Zhang’s academic excellence is reflected not only in his research citations but also in the numerous honors and scholarships he has received. These include multiple first prizes for Young Investigator Awards, outstanding doctoral dissertations, and recognitions for clinical excellence. His impressive list of awards, including the Beijing Science and Technology Award (2016) and the Outstanding Doctoral Dissertation from Peking Union Medical College (2016), highlights his leadership and commitment to medical innovation.

LEGACY AND FUTURE CONTRIBUTIONS 🔮🏅

Dr. Zhang’s legacy lies in his consistent drive to innovate and advance cardiovascular surgery. His work with various research institutions and medical centers has laid a robust foundation for the continued improvement of heart disease diagnosis and treatment. As a principal investigator for several key projects and his role on editorial boards such as the Journal of American Heart Association, Dr. Zhang is poised to influence future cardiovascular research and practice for years to come.

Looking ahead, his research into heart valve replacement and atrial fibrillation is expected to lead to new clinical strategies that will enhance patient care globally. His future contributions are expected to redefine approaches to cardiovascular health, with an emphasis on personalized medicine and novel surgical techniques.

FINAL THOUGHTS 🧠💖

Dr. Heng Zhang is a leading figure in cardiovascular medicine, combining clinical expertise with cutting-edge research to make significant advancements in heart disease treatment. His future is one of continued excellence and innovation, as he works tirelessly to shape the future of cardiovascular care, improving the lives of patients worldwide.

NOTABLE PUBLICATIONS 📑

"Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study" 

  • Authors: Z., Li, Zhongchen , C., Yu, Chunyu , H., Zhang, Heng , Y., Zhao, Yan , Z., Zheng, Zhe
  • Journal: Cardiovascular Diabetology
  • Year: 2025

"Association of stress hyperglycemia ratio with short-term and long-term prognosis in patients undergoing coronary artery bypass grafting across different glucose metabolism states: a large-scale cohort study" 

  • Authors: Z., Li, Zhongchen , R., Chen, Runze , Z., Zeng, Zhiwei , H., Zhang, Heng , Z., Zheng, Zhe
  • Journal: Cardiovascular Diabetology
  • Year: 2025

"Clinical Outcomes of Surgical Revascularization Strategies Guided by Quantitative Flow Ratio in Primary Noncoronary Cardiac Surgery" 

  • Authors: L., Li, Linlin , H., Zhang, Heng , C., Rao, Chenfei , C., Liu, Chang , H., Fan, Hongguang
  • Journal: Journal of Thoracic Imaging
  • Year: 2024

"Association of carotid duplex ultrasonography screening with stroke and mortality among patients undergoing coronary artery bypass grafting" 

  • Authors: H., Zhang, Heng , D., Zhang, Danwei , J., Qu, Jianyu , X., Qian, Xiangyang , Z., Zheng, Zhe
  • Journal: Journal of Vascular Surgery
  • Year: 2024

"Impact of High Lipoprotein(a) on Long-Term Survival Following Coronary Artery Bypass Grafting" 

  • Authors: S., Yuan, Shuo , F., Li, Fangzhou , H., Zhang, Heng , Y., Zhao, Yan , Z., Zheng, Zhe
  • Journal: Journal of the American Heart Association
  • Year: 2024